• Adaptive Biotechnologies Announces EUA for T-Detect Test americanpharmaceuticalreview
    March 15, 2021
    Adaptive Biotechnologies announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for T-Detect™ COVID to confirm recent or prior COVID-19 infection.
PharmaSources Customer Service